glp 1 in heart failure GLP-1RA Different HFpEF Phenotypes Mechanisms of GLP-1 Receptor Agonists

The cardiometabolic case for GLP-1 receptor agonists in established disease is now strong on the evidence side, not the marketing side

*Correspondence: Niklas Reich, [email protected] This article was submitted to Neurodegeneration, a section of the journal Frontiers in Neuroscience Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

These GLP-1 drugs are becoming more common, both through prescriptions from doctors and via off-label use

coli, and K, pneumoniae may be able to consume histamine, thus reducing histamine levels

Jazmin Aguilera: So this all sounds like a wonderful discovery, minus the expense of it, perhaps, and the health insurance of it all